TY  - JOUR

T1  - The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

JO  - Proceedings of the National Academy of Sciences

PY  - 2006/06/12

AU  - Boucharaba A

AU  - Serre C-M

AU  - Guglielmi J

AU  - Bordet J-C

AU  - Clezardin P

AU  - Peyruchaud O

ED  - 

DO  - DOI: 10.1073/pnas.0600979103

PB  - Proceedings of the National Academy of Sciences

VL  - 103

IS  - 25

SP  - 9643

EP  - 9648

Y2  - 2025/10/26

ER  -